APAC Hodgkin Lymphoma Treatment Market Analysis


  • Type: Oncology area
  • Published : January 2022
  • Region: APAC
  • Country: Other
  • Report ID : 5002

  • Format: PPT, PDF

APAC Hodgkin Lymphoma Treatment Market Analysis: Segmented by Type, Treatment, End-User – Growth, Market Size, Future Prospects & Competitive Analysis, 2020 – 2028

SKU: 5002 Categories: ,

Report Description of the APAC Hodgkin Lymphoma Treatment Market Analysis

Research Scope and Assumption

  • The report provides the market value for the base year 2020 and a yearly forecast up to 2028 in terms of revenue (USD billion)
  • The key industry dynamics, regulatory scenario, reimbursement scenario, major market trends, and drug markets are evaluated to understand their impacts on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis
  • We have used the combination of top-down and bottom-up approach for market sizing, analyzing key regional markets, dynamics, and trends for various solutions, services, and end uses
  • All market estimates and forecasts have been validated through primary interviews with the Key Industry Players (KIPs) and secondary analysis
  • Inflation has not been accounted for in order to estimate and forecast the market
  • Numbers may not add up due to rounding off

Reason to buy the report:

  • Facilitate decision-making based on strong current and forecast data for APAC Hodgkin Lymphoma Treatment Market Analysis
  • Develop strategies based on the latest regulatory framework
  • Strategically analyze micro-markets with respect to individual growth trends, future prospects, and their contribution to the market
  • Analyze competitive developments such as expansions, investments, mergers & acquisitions, new product developments, and research & developments in the APAC Hodgkin Lymphoma Treatment Market Analysis
  • Analyze the opportunities in the market for stakeholders and draw a competitive landscape for market leaders
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • We have technically sound team which do a deep dive research and also provide strategy based consulting analysis

APAC Hodgkin Lymphoma Treatment Market Analysis Executive Summary

Hodgkin Lymphoma is a cancer of the lymphatic system known as lymphoma. A part of the immune system. This disease is mostly common in the age group of 20 to 40 years and above the age of 55 years. In Hodgkin lymphoma, cells in the lymphatic system grow abnormally and could spread further. Advancement in the diagnosis and treatment of Hodgkin lymphoma have driven complete recovery of the patient’s condition. Symptoms of Hodgkin lymphoma are swelling of lymph nodes, persistent fatigue, fever, night sweats, and weight loss.

Market Size and Key Findings

The APAC Hodgkin Lymphoma Treatment Market Analysis size stood at around USD xx billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period owing to an increase in prevalence of Hodgkin lymphoma cancer across the region, awareness about technological advancements, and awareness about chemotherapy for treatment of Hodgkin lymphoma.0

Market Dynamics

Market Growth Drivers Analysis

Increase in incidences of Hodgkin lymphoma and availability of standard diagnostic tools such as CT scans, X-rays. Biopsy, blood tests, bone marrow enable faster diagnosis of the Hodgkin lymphoma condition. An increase in prevalence and incidences of infection by EBV are expected to drive the market. About half of cases of Hodgkin lymphoma occur due to the infection by EBV and these are generally the classic form.

Market Restraints

Side effects from cancer treatment with radiation therapy and/ or chemotherapy for HD may increase the risk of second cancers, and other health problems such as infertility, heart diseases, lung diseases, etc. may restrain the market growth.

Competitive Landscape

Key Players

The Major players into the Hodgkin lymphoma treatment market are Alkem Laboratories, Amneal Pharmaceuticals, Inc., Baxter International Inc., Biogen Inc., Bristol-Myers Squibb Company, F Hoffmann-La Roche Ltd, Incyte Corp, Merck & Co. Inc., Seattle Genetics, Inc. and Teva Pharmaceutical Industries Ltd.

Products in Pipeline

A protein called CD30 is commonly found on the surface of Hodgkin lymphoma cells. A drug called brentuximab vedotin (Adcetris) that targets this protein has been approved as part of initial treatment for people with advanced Hodgkin lymphoma. Use of this new drug may help older patients avoid what had been the standard treatment with an especially toxic chemotherapy drug. Clinical trials are now testing brentuximab vedotin combined with other chemotherapies and immunotherapies.

Notable Recent Deals

  • In June 2018 The Janssen Global Services, pharmaceutical company of Johnson and Johnson Services, Inc. announced results from a pre-planned interim analysis of the Phase 3 iNNOVATE study evaluating the investigational use of IMBRUVICA® (ibrutinib) in combination with rituximab in relapsed/refractory and treatment-naïve patients with Waldenström’s macroglobulinemia (WM) a form of lymphoma.
  • In March 2018, the drug, Adcetris (brentuximab vedotin), was approved for use in combination with a chemotherapy regimen commonly known as AVD by FDI. Seattle Genetics, Inc. and Takeda Pharmaceutical Company Limited had collaborated to sell and market this drug.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario

The Lymphoma Specialized Programs of Research Excellence (Lymphoma SPOREs) are designed to quickly move basic scientific findings into clinical settings. The Lymphoma SPOREs support the development of new immunotherapies, novel targeted therapies, and new methods for determining prognosis for individual patients.

The goal of the International Lymphoma Epidemiology Consortium (InterLymph) is to enhance collaboration among epidemiologists studying lymphoma, provide a forum for the exchange of research ideas, and create a framework for collaborating on analyses that compile data from multiple studies.

The Clinical Trial Sequencing Project (CTSP) promotes the use of genomics in NCI-sponsored clinical trials. CTSP’s goal is to clarify the molecular basis of response and resistance to therapies studied. Diffuse large B-cell lymphoma is one of the cancer types under study, along with breast and renal cell carcinoma.

Within the Center for Cancer Research, the Lymphoid Malignancies Branch focuses on identifying abnormalities in the immune system and looking at molecular disorders that underlie lymphoid malignancies.

1. Report Description of the APAC Hodgkin Lymphoma Treatment Market Analysis
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. APAC Hodgkin Lymphoma Treatment Market Analysis Executive Summary
2.1 APAC Hodgkin Lymphoma Treatment Market Analysis – Industry Snapshot & key buying criteria, 2020-2028
2.2 Market Size, Growth Prospects and Key findings
3. Market Dynamics of APAC Hodgkin Lymphoma Treatment Market Analysis
3.1 Market Growth Drivers Analysis
3.1.1 Increase in incidences
3.1.2 Availability of standard diagnostic tools
3.2 Market Restraints Analysis
3.2.1 Side Effects like the risk of second
4. APAC Hodgkin Lymphoma Treatment Market Segmentation
4.1 By Type:
4.1.1 Classical Hodgkin’s lymphoma
4.1.2 Nodular lymphocyte-predominant Hodgkin’s lymphoma
4.2 By Treatment:
4.2.1 Chemotherapy
4.2.2 Radiography
4.2.3 Immunotherapy
4.2.4 Other
4.3 By End-User:
4.3.1 Hospitals
4.3.2 Research Centre
4.3.3 Clinics
5. APAC Hodgkin Lymphoma Treatment Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
6.2 Products in Pipeline
6.3 R&D Initiatives in Hodgkin Lymphoma Treatment Market
6.4 Notable recent deals in Hodgkin Lymphoma Treatment Market
6.4.1 Joint Ventures
6.4.2 Partnerships
6.4.3 Mergers & Acquisitions
6.4.4 Strategic divestments
7. Key Company Profiles
7.1 Alkem Laboratories Company overview
Product & Services, Strategies & Financials
7.2 Amneal Pharmaceuticals, Inc. Company overview
Product & Services, Strategies & Financials
7.3 Abbott Company overview
Product & Services, Strategies & Financials
7.4 Baxter International Inc. Company overview
Product & Services, Strategies & Financials
7.5 Bristol-Myers Squibb Company overview
Product & Services, Strategies & Financials
7.6 F Hoffmann-La Roche Ltd Company overview
Product & Services, Strategies & Financials
7.7 Merck & Co. Inc. Company overview
Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
9. Factors Driving Future Growth
9.1 New Trends and Development of Hodgkin Lymphoma Treatment market
9.2 Future Opportunities
10. Strategic Recommendations

APAC Hodgkin Lymphoma Treatment Market Analysis Segmentation

By Type:

Classical Hodgkin’s lymphoma

  • Nodular sclerosis Hodgkin’s lymphoma
  • Mixed cellularity Hodgkin’s lymphoma
  • Lymphocyte-depleted Hodgkin’s lymphoma
  • Lymphocyte-rich Hodgkin’s lymphoma

Nodular lymphocyte-predominant Hodgkin’s lymphoma

By Treatment:

Based on Treatment Type, it is segmented into Chemotherapy, Radiotherapy, and Others. Radiotherapy is a well-established technique at destroying Hodgkin’s disease cells by using high-energy beams or particles to kill cancer cells and may be delivered from a source outside the body, i.e., external beam radiation or internally, such as brachytherapy. For classical Hodgkin’s disease, radiotherapy is often given after chemotherapy, especially when there is a large or bulky tumor mass.

By End-User:

Based on the End-Users the market is segmented into Hospitals, Clinics and Research Centres.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements